We are ready to help. Send us a request today!

DCV2

NATURAL KILLERS VACCINE

WHAT ARE NATURAL KILLERS?
NK cells are CD3−CD56+ large granular lymphocytes
Make up 10-15% of all peripheral blood lymphocytes
Provide an immediate immune response without the formation of immunological memory (innate immunity)
Recognize and destroy tumor and virus-infected cells
Express activating and inhibitory receptors on their surface.
Cytotoxic activity is determined by the balance between activating and inhibitory signals.


Immunotherapy using Natural killer cell (NK)-based vaccination is an approved approach for harnessing the potential of a patient's own immune system to eliminate tumor cells in metastatic hormone-refractory cancer.

How do NK cells recognize tumor cells?

1. Inhibitory NK cell receptors interact with MHC I molecules, which are expressed by almost all normal cells in the body. Binding of inhibitory receptors to MHC I prevents NK cell activation

2.Tumor cells often downregulate MHC I expression to overcome the immune response from T lymphocytes. But NK cells are able to detect the absence or change in the level of MHC I expression

3.Cellular stress and DNA damage during tumor transformation or viral infection lead to increased expression of stress ligands, which can be detected by activating NK cell receptors.




REGISTRATION

For a free online specialist consultation - fill out the feedback form.